Advantages over conventional drug delivery devices, rise in prevalence of COPD and asthma drive the growth of the global aerosol delivery devices market.
The success of any new inhaled medicine relies in a large part on the correct combination of formulation and device technology being chosen for its delivery.
Dr. Sandy Munro, Vice President – Pharmaceutical Development, Vectura01.27.21
Patch could administer vaccines without traditional needles reducing the need for refrigeration in transport and storage, and possibly self-administration.